Skip to main content

Table 4 The success rate of cefaclor for all patients and that for patients with secondary treatment

From: Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study

 All (n = 233)< 50 years (n = 34)> 50 years (n = 199) 
SuccessFailSuccessFailSuccessFailP value
All219 (94.0)14 (6.0)33 (97.1)1 (2.9)186 (93.5)13 (6.5)< 0.001
Pathogens with the failure of cefaclor
Escherichia coli156 (97.5)4 (2.5)33 (97.1)1 (2.9)128 (97.7)3 (2.3)0.975
Klebsiella species18 (94.7)1 (5.3)1 (100)017 (94.4)1 (5.6)0.971
Escherichia coli-ESBL11 (61.1)7 (38.9)1 (100)010 (58.8)7 (41.2)0.714
Staphylococcus species5 (83.3)1 (16.7)2 (100)03 (75.0)1 (25.0)0.741
Enterococcus faecalis3 (75.0)1 (25.0)003 (75.0)1 (25.0)1
  1. Unless otherwise stated, the number of patients with percentages in parentheses
  2. ESBL Extended spectrum beta-lactamase